Source: Pharmabiz

Wockhardt: Wockhardt Q1 net profit stood at Rs. 760 crore

Wockhardt Limited has reported net profit of Rs. 760 crore for the first quarter ended 30th June, 2020 as against the loss of Rs. 45 crore in the corresponding period of last year

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Habil Khorakiwala's photo - Founder & CEO of Wockhardt

Founder & CEO

Habil Khorakiwala

CEO Approval Rating


Wockhardt is a pharmaceutical and biotechnology firm that manufactures injectables and lyophilised products. Read more